Kernicterus pp 153-160 | Cite as

Non-phototherapy Treatment

  • David W. McCandless
Part of the Contemporary Clinical Neuroscience book series (CCNE)


Several treatment regimens for hyperbilirubinemia not involving phototherapy have evolved over many years. Phototherapy-based treatment is described in the next chapter. Of the non phototherapy-based treatments, some have been directed at stimulating or increasing conjugation of bilirubin, while others are attempts to reduce the levels of circulating unconjugated bilirubin.


Bilirubin Level Newborn Infant Exchange Transfusion Unconjugated Bilirubin Blood Exchange Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Akobeng, A. (2005) Neonatal jaundice. Am. Fam. Physician. 71:21–23Google Scholar
  2. Amato, M., et al. (1988) Effectiveness of single versus double volume exchange transfusion in newborn infants with ABO hemolytic disease. Helvetica Paed. Acta 43:177–186Google Scholar
  3. Black, M., Fevery, J., and Parker, D. (1974) Effect of phenobarbitone on plasma bilirubin clearance in patients with unconjugated hyperbilirubinemia. Clin. Sci. Mol. Med. 46:1–17PubMedGoogle Scholar
  4. Cohen, A., et al. (1985) Effects of phenobarbitol on bilirubin metabolism and its response to phototherapy in the jaundiced Gunn rat. Hepatology 5:310–316PubMedCrossRefGoogle Scholar
  5. Crigler, J., and Gold, N. (1969) Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital nonhemolytic unconjugated hyperbilirubinemia and kernicterus. J. Clin. Invest. 48:42–55PubMedCrossRefGoogle Scholar
  6. Hansen, T., and Tommarello, S. (1998) Effect of phenobarbital on bilirubin metabolism in rat brain. Biol. Neonate. 73:106–111PubMedCrossRefGoogle Scholar
  7. Jackson, J. (1997) Adverse effects associated with exchange transfusion in healthy and ill newborns. Pediatr. 99: e7–e22CrossRefGoogle Scholar
  8. Maurer, H., et al. (1968) Reduction in concentration of total serum bilirubin in offspring of women treated with phenobarbitone during pregnancy. Lancet 2:122–124PubMedCrossRefGoogle Scholar
  9. Milligan, T. (2006) Single vrs double volume exchange transfusion in jaundiced newborn infants. Cochrane Database Syst Rev. Wiley 1–63Google Scholar
  10. Newman, T., et al. (2006) Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N. Engl. J. Med. 354:1889–1900PubMedCrossRefGoogle Scholar
  11. Okuda, H., et al. (1989) Dose related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligand levels in the rat. Drug Metab. Dispos. 17:677–682PubMedGoogle Scholar
  12. Schroter, W. (1980) Successful long term phenobarbital therapy of hyperbilirubinemia in congenital hemolytic anemia due to glucose phosphate isomerase deficiency. Eur. J. Pediatr. 135:41–43PubMedCrossRefGoogle Scholar
  13. Seppen, J., et al. (1996) Bilirubin glucuronidation by intact Gunn rat fibroblasts expressing bilirubin UDP-glucuronosyltransferase. Biochem. J. 314:477–483PubMedGoogle Scholar
  14. Stanley, I., et al. (2004) An evidence based review of important issues Concerning neonatal hyperbilirubinemia, Pediatr. 114:130–153.CrossRefGoogle Scholar
  15. Stern, L., et al. (1970) Effect of phenobarbitol on hyperbilirubinemia and glucuronide formation in newborns. Arch. Pediatr. Adol. Med. 120:26–31CrossRefGoogle Scholar
  16. Trolle, D. (1968) Decrease of total serum bilirubin concentration in newborn infants after phenobarbitone treatment. Lancet 2:705–708PubMedCrossRefGoogle Scholar
  17. Watchko, J. (2006) Neonatal hyperbilirubinemia-What are the risks? N. Engl. J. Med. 354:1947–1949PubMedCrossRefGoogle Scholar
  18. WHO Severe and complicated malaria: A report of the WHO malaria action programme. Trans. R. Soc. Med. Hyg. 80:1–50Google Scholar
  19. Yin, J., Miller, M., and Wennberg, R. (1991) Induction of hepatic bilirubin metabolizing enzymes by the traditional Chinese medicine yin zhi huang. Dev. Pharmacol. Ther. 16:176–184PubMedGoogle Scholar
  20. Springer, S., and Annibale, D. (2008) Kernicterus: treatment and medication. eMedicine972576Google Scholar
  21. Yeung, C. and Yu, V. (1971) Phenobarbitone enhancement of bromosulphalein clearance in neonatal hyperbilirubinemia. Pediatr. 48:556–561Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Cell Biology & AnatomyRosalind Franklin University of Medicine & Science, Chicago Medical SchoolNorth ChicagoUSA

Personalised recommendations